Clinical Trials Logo

Clinical Trial Summary

An prospective observetional study to asses the predictive value of serum uric acid to high density lipoprotein cholesterol ratio for diabetic kidney injury in type 2 diabetes


Clinical Trial Description

Diabetic Kidney Injury (DKI) is a serious microvascular complication of diabetes mellitus occuring in about 20 % to 50% of diabetic patients and is the single commonest cause of ESRD.DKI is asociated with arterial HTN and increased cardiovascular morbidity and mortality. outcomes for both type 1 DM and type 2 DM who develop DKI are significantly worse than who do not .Serum uric acid was reported to be asociated with inflamatory and metabolic diseases such as metabolic syndrome , type 2 DM,thyroiditis and NAFLD while HDL-cholesterol decreased the odds of developing DKI by 20%.It is generally accepted that hyperuricemia and low HDL-c were considered to be a risk factor of other indicators for development of DKI. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06349850
Study type Observational
Source Sohag University
Contact Eldeeb E. Mohamed, Resident
Phone 01092700322
Email deebbayern13@gmail.com
Status Not yet recruiting
Phase
Start date June 2024
Completion date September 2024